日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SAT-796 REMS Suitability in Endocrine-Related Bone Disorders

SAT-796 REMS 在内分泌相关骨骼疾病中的适用性

Andersen, Courtney L; Sikora, Matthew J; Boisen, Michelle M; Ma, Tianzhou; Christie, Alec; Tseng, George; Park, Yongseok; Luthra, Soumya; Chandran, Uma; Haluska, Paul; Mantia-Smaldone, Gina M; Odunsi, Kunle; McLean, Karen; Lee, Adrian V; Elishaev, Esther; Edwards, Robert P; Oesterreich, Steffi; Luna, Eduardo Dusty

Association of neighborhood social vulnerability with ovarian cancer survival

社区社会脆弱性与卵巢癌生存率之间的关联

Borho, Lauren; Elishaev, Esther; Bao, Riyue; O'Brien, Emily; Dinkins, Kaitlyn; Berger, Jessica; Boisen, Michelle; Comerci, John; Courtney-Brooks, Madeleine; Edwards, Robert P; Garrett, Alison Aunkst; Kelley, Joseph L; Lesnock, Jamie; Mahdi, Haider S; Olawaiye, Alexander; Rush, Shannon; Sukumvanich, Paniti; Taylor, Sarah; Aneja, Ritu; Norian, Lyse; Arend, Rebecca C; Modugno, Francesmary

All-cause mortality and neighborhood social vulnerability among women with ovarian cancer

卵巢癌女性的全因死亡率和社区社会脆弱性

Hicks, Austin; Borho, Lauren; Elishaev, Esther; Berger, Jessica; Boisen, Michelle; Comerci, John; Courtney-Brooks, Madeleine; Edwards, Robert P; Garrett, Alison Aunkst; Kelley, Joseph L; Lesnock, Jamie; Mahdi, Haider S; Olawaiye, Alexander; Rush, Shannon; Sukumvanich, Paniti; Taylor, Sarah; Modugno, Francesmary

Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancer

血清补体激活、中性粒细胞胞外陷阱和细胞外DNA在初诊上皮性卵巢癌中的预后意义

Ricciuti, Jason; Liu, Qian; Khan, A N M Nazmul H; Joseph, Janine M; Veuskens, Bert; Giridharan, Thejaswini; Suzuki, Sora; Emmons, Tiffany; Yaffe, Michael; Kuijpers, Taco W; Jongerius, Ilse; Brouwer, Mieke; Pouw, Richard B; Odunsi, Kunle; Frederick, Peter; Mager, Katherine LaVigne; Lele, Shashikant; Gaulin, Nicole; Hakim, Christiane; Edwards, Robert P; Olawaiye, Alexander B; Sukamanovich, Paniti; Taylor, Sarah; Elishaev, Esther; Zsiros, Emese; Modugno, Francesmary; Moysich, Kirsten; Segal, Brahm

Association of allostatic load with overall survival in epithelial ovarian cancer

异质性负荷与上皮性卵巢癌总生存期的相关性

Borho, Lauren; Bao, Riyue; Elishaev, Esther; Dinkins, Kaitlyn D; O'Brien, Emily E; Berger, Jessica; Boisen, Michelle; Comerci, John; Courtney-Brooks, Madeleine; Edwards, Robert P; Garrett, Alison Aunkst; Kelley, Joseph L; Lesnock, Jamie; Mahdi, Haider S; Olawaiye, Alexander; Rush, Shannon; Sukumvanich, Paniti; Taylor, Sarah; Arend, Rebecca C; Norian, Lyse; Modugno, Francesmary

Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition

靶向 CD47-SIRPa 轴作为单药疗法显示出强大的临床前抗肿瘤活性,并且与 PARP 抑制剂具有协同作用。

Al-Sudani, Hussein; Ni, Ying; Jones, Philip; Karakilic, Huseyin; Cui, Lei; Johnson, Lisa D S; Rose, Peter G; Olawaiye, Alexander; Edwards, Robert P; Uger, Robert A; Lin, Gloria H Y; Mahdi, Haider

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

IL-12 和 PD-1/CTLA-4 抑制剂免疫疗法对晚期卵巢癌有效,并可逆转髓系细胞诱导的免疫抑制。

Pavicic, Paul G Jr; Rayman, Patricia A; Swaidani, Shadi; Rupani, Amit; Makarov, Vladimir; Tannenbaum, Charles S; Edwards, Robert P; Vlad, Anda M; Diaz-Montero, C Marcela; Mahdi, Haider

Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)

WRITE症状干预对复发性卵巢癌患者症状和生活质量的影响:NRG肿瘤/GOG研究(GOG-0259)

Donovan, Heidi S; Sereika, Susan M; Wenzel, Lari B; Edwards, Robert P; Knapp, Judith E; Hughes, Susan H; Roberge, Mary C; Thomas, Teresa H; Klein, Sara Jo; Spring, Michael B; Nolte, Susan; Landrum, Lisa M; Casey, A Catherine; Mutch, David G; DeBernardo, Robert L; Muller, Carolyn Y; Sullivan, Stephanie A; Ward, Sandra E

Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity

一项将趋化因子靶向治疗与局部区域化疗免疫疗法相结合治疗复发性铂敏感卵巢癌的I期临床试验显示,CXCR3配体和1型免疫标志物均被诱导表达。

Orr, Brian; Mahdi, Haider; Fang, Yusi; Strange, Mary; Uygun, Ibrahim; Rana, Mainpal; Zhang, Lixin; Suarez Mora, Adria; Pusateri, Alexandra; Elishaev, Esther; Kang, Chaeryon; Tseng, George; Gooding, William; Edwards, Robert P; Kalinski, Pawel; Vlad, Anda M

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer

瑞博西尼联合铂类化疗治疗卵巢癌的I期临床试验

Coffman, Lan G; Orellana, Taylor J; Liu, Tianshi; Frisbie, Leonard G; Normolle, Daniel; Griffith, Kent; Uppal, Shitanshu; McLean, Karen; Berger, Jessica; Boisen, Michelle; Courtney-Brooks, Madeleine; Edwards, Robert P; Lesnock, Jamie; Mahdi, Haider; Olawaiye, Alexander; Sukumvanich, Paniti; Taylor, Sarah E; Buckanovich, Ronald